Pancreatic Cancer Research

ResearcherFox Chase Cancer CenterNo recent work listed

Eileen A. O’Halloran

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4783-6847; OpenAlex author ID A5018131284. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

  1. Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma. First author DOI 10.1002/jso.26906↗
  2. Predicting positive peritoneal cytology in pancreatic cancer. Co-author DOI 10.1007/s00432-020-03471-9↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sanjay S. Reddy · 2 shared papers, 2021–2022 · strength 0.32
  2. Dany Barrak · 1 shared paper, 2022 · strength 0.17
  3. Neha Goel · 1 shared paper, 2022 · strength 0.17
  4. Anthony M. Villano · 1 shared paper, 2022 · strength 0.17
  5. Efrat Dotan · 1 shared paper, 2021 · strength 0.15
  6. Joshua E. Meyer · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.